Corporate VC

Colorcon Ventures

Investment Details

Investor Type
Corporate VC

Asset Class Focus
Venture Capital

Stage Focus
Early Stage, Mid Stage

Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, Brazil, France, Spain, Mexico, South Korea, Bangladesh, Malaysia, New Zealand, Portugal, Argentina, Colombia, Venezuela

Industries Focus

  • Healthcare
  • Artificial Intelligence
  • Digital Health
  • Pharmaceuticals
  • Medical Devices
  • Manufacturing
  • Food Technology
  • Machine Learning
  • Biotechnology
  • Supply Chain
  • Personalized Medicine
  • 3D Printing
  • Nutrition
  • Nutraceuticals
  • Clinical Nutrition

Investment Size:
500,000 to 2,500,000 USD

Investor Details Founded: 2019

Colorcon Ventures is the corporate venture fund of Colorcon Inc., focusing on investments in transformative technologies within the pharmaceutical and nutraceutical sectors. The fund primarily targets early and mid-stage companies that demonstrate product-market fit and revenue growth, aligning with Colorcon's expertise in pharmaceutical innovation. Their investment areas include technologies that enhance patient compliance, combat counterfeiting, and disrupt traditional dosage delivery methods. Additionally, Colorcon Ventures is interested in smart solutions for digital and personalized medicine, breakthrough manufacturing innovations, and intelligent systems addressing unmet needs across pharmaceutical technologies and supply chains. The fund is not investing in companies developing active pharmaceutical ingredients or therapeutic molecules. Colorcon Ventures offers a $50 million fund dedicated to pharmaceutical and nutraceutical advancements, with initial investments ranging from $0.5 million to $2.5 million, and reserved capital for follow-on funding. They co-invest with top-tier venture capital firms to maximize value for startups in the pharma space. Their portfolio includes companies like Syntis Bio, Atomwise, i2O Therapeutics, Remedy Health, VeriSIM Life, Apprentice, Mend, Vedanta, and Phytolon, each contributing to advancements in drug delivery, AI-driven drug discovery, personalized nutrition, and more. The team comprises industry-leading experts in pharmaceutical excipients, coating systems, and modified release technologies, bringing decades of experience in transforming pharmaceutical development and manufacturing. Together with Cerity Partners, a trusted partner in corporate venture capital, they aim to maximize value for startups in the pharma space. Colorcon Ventures is looking for innovative startups ready to scale, offering support through commercial consultation, guidance on sales and scientific development, and leveraging Colorcon's global reach and industry relationships to accelerate growth and create lasting impact. For more information, visit their official website or follow @ColorconVC.

Requirements
  • Early and mid-stage companies with product-market fit and revenue growth
  • Innovative solutions in pharmaceutical and nutraceutical industries
  • Technologies enhancing patient compliance and combating counterfeiting
  • Disruptive dosage delivery methods
  • Smart solutions for digital and personalized medicine
  • Breakthrough manufacturing innovations
  • Intelligent systems addressing unmet needs in pharmaceutical technologies and supply chains
  • Companies not developing active pharmaceutical ingredients or therapeutic molecules
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

Portfolio Companies
  • Syntis Bio
  • Atomwise
  • i2O Therapeutics
  • Remedy Health
  • VeriSIM Life
  • Apprentice
  • MEND
  • Vedanta
  • Phytolon
Claim this Investor

Are you an official representative of Colorcon Ventures?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim